Neuropeptide S produces antinociceptive effects at the supraspinal level in mice

[1]  Wei Li,et al.  Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice , 2009, Peptides.

[2]  J. Quevedo,et al.  Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: A comparative study with amphetamine and diazepam , 2009, Pharmacology Biochemistry and Behavior.

[3]  S. Salvadori,et al.  In Vitro and in Vivo Pharmacological Characterization of the Neuropeptide S Receptor Antagonist [d-Cys(tBu)5]Neuropeptide S , 2009, Journal of Pharmacology and Experimental Therapeutics.

[4]  S. Salvadori,et al.  Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists. , 2009, Journal of medicinal chemistry.

[5]  G. Calo’,et al.  Anxiolytic-like effect of neuropeptide S in the rat defensive burying , 2008, Peptides.

[6]  S. Salvadori,et al.  Structure-activity study at positions 3 and 4 of human neuropeptide S. , 2008, Bioorganic & medicinal chemistry.

[7]  R. Stewart,et al.  The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats. , 2008, Alcoholism, clinical and experimental research.

[8]  H. Pape,et al.  Neuropeptide S-Mediated Control of Fear Expression and Extinction: Role of Intercalated GABAergic Neurons in the Amygdala , 2008, Neuron.

[9]  S. Runyon,et al.  Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for Neuropeptide S antagonist activity. , 2008, Bioorganic & medicinal chemistry letters.

[10]  J. Kere,et al.  Biological and genetic interaction between tenascin C and neuropeptide S receptor 1 in allergic diseases. , 2008, Human molecular genetics.

[11]  R. Reinscheid,et al.  Synthesis and Pharmacological in Vitro and in Vivo Profile of 3-Oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic Acid 4-Fluoro-benzylamide (SHA 68), a Selective Antagonist of the Neuropeptide S Receptor , 2008, Journal of Pharmacology and Experimental Therapeutics.

[12]  S. Salvadori,et al.  Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice , 2008, British journal of pharmacology.

[13]  C. Beyer,et al.  Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders , 2008, Psychopharmacology.

[14]  J. Kere,et al.  The protective effect of farm animal exposure on childhood allergy is modified by NPSR1 polymorphisms , 2008, Journal of Medical Genetics.

[15]  S. Salvadori,et al.  Synthesis and biological activity of human neuropeptide S analogues modified in position 2. , 2008, Journal of medicinal chemistry.

[16]  R. Reinscheid.  Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. , 2008, Results and problems in cell differentiation.

[17]  C. Diéguez,et al.  Nicotine treatment regulates neuropeptide S system expression in the rat brain. , 2007, Neurotoxicology.

[18]  M. Cline,et al.  Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus). , 2007, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[19]  K. Hashimoto,et al.  Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  C. Lindgren,et al.  Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. , 2007, Gastroenterology.

[21]  R. Reinscheid.  Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods , 2007, Peptides.

[22]  C. Gall,et al.  Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S‐expressing neurons in the rat brain , 2007, The Journal of comparative neurology.

[23]  C. Diéguez,et al.  Caffeine treatment regulates neuropeptide S system expression in the rat brain , 2006, Neuroscience Letters.

[24]  R. Stocco,et al.  Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[25]  Christopher M. Tan,et al.  Structure-Function Relationships in the Neuropeptide S Receptor , 2006, Journal of Biological Chemistry.

[26]  M. Niimi.  Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats , 2006, Endocrine.

[27]  S. Salvadori,et al.  Structure-Activity Studies on Neuropeptide S , 2006, Journal of Biological Chemistry.

[28]  S. Bloom,et al.  Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. , 2006, Endocrinology.

[29]  Wei Li,et al.  Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor , 2006, Regulatory Peptides.

[30]  J. Kere,et al.  Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses. , 2006, Human molecular genetics.

[31]  R. Reinscheid,et al.  Neuropeptide S and Its Receptor: A Newly Deorphanized G Protein–Coupled Receptor System , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[32]  Shinjae Chung,et al.  Pharmacological Characterization of Human and Murine Neuropeptide S Receptor Variants , 2005, Journal of Pharmacology and Experimental Therapeutics.

[33]  R. Reinscheid,et al.  Neuropeptide S as a novel arousal promoting peptide transmitter , 2005, The FEBS journal.

[34]  Wei Li,et al.  Structure–activity studies on different modifications of nociceptin/orphanin FQ: Identification of highly potent agonists and antagonists of its receptor , 2005, Regulatory Peptides.

[35]  B. Beck,et al.  Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. , 2005, Biochemical and biophysical research communications.

[36]  J. Kere,et al.  Characterization of GPRA, a novel G protein-coupled receptor related to asthma. , 2005, American journal of respiratory cell and molecular biology.

[37]  O. Civelli,et al.  Neuropeptide S: a new player in the modulation of arousal and anxiety. , 2005, Molecular interventions.

[38]  S. Henriksen,et al.  Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. , 2004, Neuron.

[39]  David Fitzpatrick,et al.  Neuroscience, 3rd ed. , 2004 .

[40]  M. Millan.  Descending control of pain , 2002, Progress in Neurobiology.

[41]  R. Hurley,et al.  A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist , 2001, Pain.

[42]  S. Hyman,et al.  Molecular Neuropharmacology: A Foundation for Clinical Neuroscience , 2001 .

[43]  J. Jhamandas,et al.  Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors. , 2000, Journal of neurophysiology.

[44]  H. Fields,et al.  A Cellular Mechanism for the Bidirectional Pain-Modulating Actions of Orphanin FQ/Nociceptin , 2000, Neuron.

[45]  A. Herz,et al.  Endogenous opioid peptides in the descending control of nociceptive responses of spinal dorsal horn neurons. , 1988, Progress in brain research.